Recently, Yoshida et al (27) reported that the NKX2.2 gene, as an important target of EWS-FLI1, is a valuable marker for PNET, with a sensitivity of 93% and a specificity of 89%. This evidence concerns the gene NKX2-2 and primitive neuroectodermal tumor.